si:dkey-261e22.4 Antibody

What is si:dkey-261e22.4 and what is its significance in zebrafish?

Si:dkey-261e22.4 is a protein-coding gene located on chromosome 4 in the zebrafish genome. It is orthologous to the human gene C12orf75 (chromosome 12 open reading frame 75) . The gene belongs to the "Overexpressed in colon carcinoma 1" protein family (InterPro ID: IPR029133) . While specific functional data remains limited, its evolutionary conservation suggests biological importance. Research on this gene may provide insights into conserved functions between zebrafish and humans, potentially relevant to developmental processes or disease mechanisms.

Why are antibodies against si:dkey-261e22.4 valuable for research?

Antibodies against si:dkey-261e22.4 would enable researchers to:

• Detect protein expression patterns during zebrafish development

• Perform protein localization studies via immunohistochemistry

• Conduct protein-protein interaction studies through co-immunoprecipitation

• Validate gene knockdown or knockout models

• Investigate the protein's role in response to environmental toxicants, as suggested by its inclusion in toxicity studies

The development of specific antibodies would significantly enhance research capabilities for studying this protein's function, particularly in toxicological responses where the gene has been implicated.

What approaches can be used to develop antibodies against si:dkey-261e22.4?

Since commercial antibodies for si:dkey-261e22.4 appear to be unavailable , researchers have several options:

• Custom Antibody Development:

  • Identify antigenic epitopes within the si:dkey-261e22.4 protein sequence

  • Design synthetic peptides corresponding to unique regions

  • Immunize rabbits or other host animals

  • Perform affinity purification of the resulting antibodies

• Recombinant Protein Expression:

  • Clone the full si:dkey-261e22.4 coding sequence

  • Express the protein in bacterial, insect, or mammalian expression systems

  • Purify the recombinant protein for immunization

• Genetic Tagging Approaches:

  • Create transgenic zebrafish lines expressing tagged versions of si:dkey-261e22.4

  • Use CRISPR/Cas9 to insert epitope tags into the endogenous locus

  • Leverage commercial antibodies against common tags (FLAG, HA, etc.)

Each approach has distinct advantages depending on research needs and available resources.

How can researchers validate antibodies against si:dkey-261e22.4?

Thorough validation is essential for antibody specificity, particularly for zebrafish proteins with limited previous characterization:

• Western Blot Validation:

  • Test antibody against zebrafish tissue lysates

  • Include appropriate controls (e.g., morpholino knockdown or CRISPR/Cas9 knockout)

  • Verify band size matches predicted molecular weight of si:dkey-261e22.4 protein

• Immunohistochemistry Validation:

  • Compare staining patterns with mRNA expression data

  • Perform peptide competition assays

  • Test specificity in gene knockout models

• Cross-Reactivity Assessment:

  • Test against related zebrafish proteins

  • Evaluate potential cross-reactivity with human orthologs if conducting comparative studies

• Reproducibility Testing:

  • Validate antibody performance across different zebrafish strains

  • Test across multiple developmental stages

How can si:dkey-261e22.4 antibodies be used in toxicological research?

Si:dkey-261e22.4 has been identified in transcriptomic analyses investigating PFOS toxicity in zebrafish embryos , suggesting potential applications in toxicology research:

• Protein Expression Changes:

  • Quantify protein expression changes following toxicant exposure

  • Compare transcriptional and translational responses

• Tissue-Specific Responses:

  • Map protein localization changes in response to toxicants

  • Identify target tissues for specific compounds

• Biomarker Development:

  • Evaluate si:dkey-261e22.4 protein levels as potential biomarkers for toxicant exposure

  • Correlate protein expression with phenotypic outcomes

• Mechanism Elucidation:

  • Investigate protein-protein interactions altered by toxicant exposure

  • Determine subcellular localization changes in response to stressors

Methodologically, researchers should design dose-response and time-course studies to characterize how this protein responds to environmental contaminants.

What techniques can be employed for studying si:dkey-261e22.4 protein interactions?

Understanding protein interactions is crucial for elucidating function:

• Co-Immunoprecipitation (Co-IP):

  • Use si:dkey-261e22.4 antibodies to pull down the protein and associated partners

  • Identify interacting proteins via mass spectrometry

  • Validate interactions with targeted western blotting

• Proximity Labeling Approaches:

  • Create fusion proteins with BioID or APEX2

  • Identify proximal proteins through biotinylation and streptavidin pulldown

  • Particularly useful if direct interactions are transient

• Yeast Two-Hybrid Screening:

  • Use si:dkey-261e22.4 as bait to screen for interacting partners

  • Validate candidates through orthogonal methods

• Fluorescence Resonance Energy Transfer (FRET):

  • Create fluorescently tagged versions of si:dkey-261e22.4

  • Measure protein-protein interactions in living cells

  • Particularly valuable for dynamic interaction studies

These approaches can help place si:dkey-261e22.4 within biological pathways and networks.

How should researchers approach studying si:dkey-261e22.4 in the context of its human ortholog C12orf75?

Comparative studies between zebrafish si:dkey-261e22.4 and human C12orf75 require careful experimental design:

• Sequence Homology Analysis:

  • Perform detailed sequence alignments to identify conserved domains

  • Focus antibody development on conserved epitopes if cross-species studies are planned

  • Determine sequence divergence that might affect antibody cross-reactivity

• Functional Conservation Testing:

  • Develop rescue experiments using human C12orf75

  • Test if human protein can complement zebrafish knockouts

  • Evaluate conservation of interaction partners

• Expression Pattern Comparison:

  • Compare tissue-specific expression between species

  • Identify developmental timing differences in expression

  • Correlate with conserved or divergent phenotypes

This comparative approach can provide insights into evolutionarily conserved functions and potential relevance to human biology or disease.

What challenges might researchers encounter when developing antibodies against the si:dkey-261e22.4 protein?

Several technical challenges are worth considering:

• Protein Size Considerations:

  • The protein is relatively small (61 amino acids)

  • Limited epitope options may complicate antibody development

  • May require specialized approaches for small protein antigens

• Specificity Concerns:

  • Potential cross-reactivity with related protein families

  • Need for extensive validation across tissues and developmental stages

  • Challenging to distinguish from related proteins

• Expression Level Challenges:

  • Potentially low endogenous expression levels

  • May require signal amplification methods for detection

  • Optimization of fixation and retrieval methods for immunohistochemistry

• Structural Considerations:

  • Unknown three-dimensional structure may affect epitope accessibility

  • Post-translational modifications could interfere with antibody binding

  • Subcellular localization might require specialized extraction methods

Researchers should consider these factors when planning antibody development projects.

How can RNA-Seq data inform antibody development and experimental design for si:dkey-261e22.4 studies?

RNA-Seq data, such as that referenced in the PFOS toxicity study , provides valuable information for antibody development:

• Expression Timing and Localization:

  • Identify developmental stages with highest expression

  • Target tissues with confirmed transcript presence

  • Optimize experimental design around known expression patterns

• Transcript Variant Analysis:

  • Identify potential splice variants

  • Ensure antibodies target conserved regions across variants

  • Consider isoform-specific antibodies if relevant

• Co-expression Network Analysis:

  • Identify genes co-expressed with si:dkey-261e22.4

  • Infer potential functional pathways

  • Guide protein interaction studies based on co-expression data

• Experimental Condition Selection:

  • Design experiments around conditions known to modulate gene expression

  • Target developmental timepoints with dynamic expression changes

  • Consider toxicants or stimuli that significantly affect expression

RNA-Seq data alignment to the zebrafish reference genome (GRCz10/11) provides a foundation for understanding transcriptional regulation that can inform protein-level studies .

What is the recommended workflow for characterizing si:dkey-261e22.4 when antibodies are unavailable?

Researchers can follow this sequential approach:

• Transcript Characterization:

  • Perform qPCR to validate expression across tissues and developmental stages

  • Use in situ hybridization to determine spatial expression patterns

  • Confirm transcript structure through 5' and 3' RACE

• Genetic Manipulation:

  • Generate CRISPR/Cas9 knockout or knockdown models

  • Create transgenic reporter lines using the si:dkey-261e22.4 promoter

  • Develop epitope-tagged knock-in lines

• Functional Assays:

  • Characterize phenotypes resulting from gene disruption

  • Perform rescue experiments to confirm specificity

  • Test responses to environmental stressors or toxicants

• Protein Detection Alternatives:

  • Express tagged recombinant proteins for localization studies

  • Use mass spectrometry for protein detection and quantification

  • Consider proximity labeling approaches for interaction studies

This workflow provides a comprehensive characterization even when specific antibodies are unavailable.

How can researchers effectively analyze si:dkey-261e22.4 in the context of toxicological studies?

Based on its appearance in PFOS toxicity research , the following approaches are recommended:

• Dose-Response Assessment:

  • Measure transcript and protein levels across toxicant concentrations

  • Correlate molecular changes with morphological phenotypes

  • Establish threshold concentrations for response

• Temporal Dynamics:

  • Analyze expression changes across exposure durations

  • Determine acute versus chronic response patterns

  • Identify critical windows of sensitivity

• Mechanistic Investigation:

  • Use pathway inhibitors to dissect regulatory mechanisms

  • Perform co-expression analysis with known toxicity response genes

  • Investigate interaction with xenobiotic metabolism pathways

• Cross-Species Comparison:

  • Compare responses between zebrafish and mammalian models

  • Evaluate conservation of toxicity pathways

  • Assess translational relevance to human health

These approaches can help establish whether si:dkey-261e22.4 serves as a biomarker or mechanistic component of toxicant response pathways.

What emerging technologies could enhance si:dkey-261e22.4 antibody development and application?

Several cutting-edge approaches may benefit research on this gene:

• Machine Learning for Antibody Design:

  • Apply computational epitope prediction algorithms

  • Use structural modeling to enhance antibody specificity

  • Leverage active learning approaches to improve antibody-antigen binding prediction

• Single-Cell Proteomics:

  • Analyze protein expression at single-cell resolution

  • Identify cell populations expressing si:dkey-261e22.4

  • Correlate with single-cell transcriptomics data

• CRISPR Display Technologies:

  • Develop in vivo tagging strategies for endogenous visualization

  • Create split-protein complementation systems for interaction studies

  • Implement optogenetic control of protein function

• Nanobody Development:

  • Consider smaller antibody formats for improved tissue penetration

  • Develop intrabodies for live-cell imaging applications

  • Create modular detection systems for multiplex applications

These technologies may overcome current limitations in studying this relatively uncharacterized zebrafish protein.

How might the study of si:dkey-261e22.4 contribute to understanding human C12orf75 function?

As the ortholog of human C12orf75, zebrafish research provides valuable comparative insights:

• Evolutionary Conservation Analysis:

  • Determine functionally conserved domains

  • Identify species-specific adaptations

  • Map constraints on protein evolution

• Disease Model Development:

  • Create zebrafish models of human conditions associated with C12orf75

  • Perform high-throughput phenotypic screening

  • Test potential therapeutic interventions

• Developmental Function Elucidation:

  • Compare developmental roles between species

  • Identify conserved interacting partners

  • Determine if human protein can rescue zebrafish mutants

The zebrafish model offers advantages in terms of visualization, genetic manipulation, and high-throughput screening that can complement human cell-based studies.

How can researchers address non-specific binding when using custom antibodies against si:dkey-261e22.4?

Non-specific binding is a common challenge, especially with newly developed antibodies:

• Optimization Strategies:

  • Titrate antibody concentrations systematically

  • Test various blocking agents (BSA, milk, normal serum)

  • Optimize incubation times and temperatures

  • Try different detergents and washing protocols

• Validation Approaches:

  • Use knockout/knockdown controls

  • Perform peptide competition assays

  • Compare multiple antibodies targeting different epitopes

  • Include isotype controls

• Sample Preparation Considerations:

  • Optimize fixation protocols for immunohistochemistry

  • Test different extraction buffers for western blotting

  • Consider native versus denaturing conditions

  • Evaluate cross-linking strategies for capturing transient interactions

• Signal Enhancement Methods:

  • Implement tyramide signal amplification for low-abundance proteins

  • Use secondary antibody amplification systems

  • Consider proximity ligation assays for improved specificity

Systematic optimization and rigorous controls are essential for distinguishing specific from non-specific signals.

What strategies can help reconcile discrepancies between transcript and protein expression data for si:dkey-261e22.4?

Discrepancies between RNA and protein levels are common and may provide biological insights:

• Technical Verification:

  • Confirm assay specificity for both transcript and protein detection

  • Use multiple primer pairs and antibodies targeting different regions

  • Include appropriate controls for each method

• Biological Explanations:

  • Investigate post-transcriptional regulation (miRNAs, RNA binding proteins)

  • Examine protein stability and turnover rates

  • Consider subcellular localization affecting detection

  • Evaluate developmental or stimulus-dependent translation control

• Temporal Analysis:

  • Perform time-course studies to capture delays between transcription and translation

  • Measure half-lives of mRNA versus protein

  • Examine dynamic responses to stimuli at both levels

• Methodological Approaches:

  • Combine ribosome profiling with RNA-Seq and proteomics

  • Use reporter constructs to monitor translation efficiency

  • Implement PUNCH-P or similar techniques to measure nascent protein synthesis

Understanding such discrepancies may reveal important regulatory mechanisms controlling si:dkey-261e22.4 expression.